docs/_posts/Ahmetemintek/2022-08-03-explain_clinical_doc_radiology_en_3_0.md
docs/_posts/Ahmetemintek/2022-08-23-drug_ade_mapper_en.md
docs/_posts/Cabir40/2022-08-12-ner_clinical_bert_ro_3_0.md
docs/_posts/Cabir40/2022-08-15-ner_deid_generic_bert_ro_3_0.md
docs/_posts/Damla-Gurbaz/2022-08-10-explain_clinical_doc_medication_en_3_0.md
docs/_posts/Meryem1425/2022-08-04-bert_sequence_classifier_treatment_changes_sentiment_tweet_en_3_0.md
docs/_posts/alierenak/2022-08-09-bert_sequence_classifier_depression_en_3_0.md
docs/_posts/alierenak/2022-08-09-bert_sequence_classifier_depression_twitter_en_3_0.md
docs/_posts/alierenak/2022-08-10-bert_sequence_classifier_depression_binary_en_3_0.md
docs/_posts/alierenak/2022-08-10-bert_sequence_classifier_health_mentions_bert_de_3_0.md
docs/_posts/alierenak/2022-08-10-bert_sequence_classifier_health_mentions_gbert_de_3_0.md
docs/_posts/alierenak/2022-08-10-bert_sequence_classifier_health_mentions_gbert_large_de_3_0.md
docs/_posts/alierenak/2022-08-10-bert_sequence_classifier_health_mentions_medbert_de_3_0.md
docs/_posts/galiph/2022-08-01-medication_resolver_pipeline_en_3_0.md
docs/_posts/gpirge/2022-08-08-bert_sequence_classifier_health_mandates_premise_tweet_en_3_0.md
docs/_posts/gpirge/2022-08-08-bert_sequence_classifier_health_mandates_stance_tweet_en_3_0.md
docs/_posts/gpirge/2022-08-11-bert_token_classifier_negation_uncertainty_es_3_0.md
docs/_posts/gpirge/2022-08-11-bert_token_classifier_ner_clinical_trials_abstracts_es_3_0.md
docs/_posts/gpirge/2022-08-11-bert_token_classifier_pharmacology_es_3_0.md
docs/_posts/gpirge/2022-08-12-ner_clinical_trials_abstracts_es_3_0.md
docs/_posts/gpirge/2022-08-13-ner_negation_uncertainty_es_3_0.md
docs/_posts/gpirge/2022-08-13-ner_pharmacology_es_3_0.md
docs/_posts/gpirge/2022-08-14-disease_mentions_tweet_es_3_0.md
docs/_posts/muhammetsnts/2022-08-28-ner_profiling_biobert_en.md
docs/_posts/muhammetsnts/2022-08-29-zero_shot_ner_roberta_en.md
docs/_posts/muhammetsnts/2022-08-30-ner_profiling_clinical_en.md
docs/_posts/Ahmetemintek/2022-08-03-explain_clinical_doc_radiology_en_3_0.md
docs/_posts/Ahmetemintek/2022-08-23-drug_ade_mapper_en.md
docs/_posts/Cabir40/2022-08-12-ner_clinical_bert_ro_3_0.md
docs/_posts/Cabir40/2022-08-15-ner_deid_generic_bert_ro_3_0.md
docs/_posts/Damla-Gurbaz/2022-08-10-explain_clinical_doc_medication_en_3_0.md
docs/_posts/Meryem1425/2022-08-04-bert_sequence_classifier_treatment_changes_sentiment_tweet_en_3_0.md
docs/_posts/alierenak/2022-08-09-bert_sequence_classifier_depression_en_3_0.md
docs/_posts/alierenak/2022-08-09-bert_sequence_classifier_depression_twitter_en_3_0.md
docs/_posts/alierenak/2022-08-10-bert_sequence_classifier_depression_binary_en_3_0.md
docs/_posts/alierenak/2022-08-10-bert_sequence_classifier_health_mentions_bert_de_3_0.md
docs/_posts/alierenak/2022-08-10-bert_sequence_classifier_health_mentions_gbert_de_3_0.md
docs/_posts/alierenak/2022-08-10-bert_sequence_classifier_health_mentions_gbert_large_de_3_0.md
docs/_posts/alierenak/2022-08-10-bert_sequence_classifier_health_mentions_medbert_de_3_0.md
docs/_posts/galiph/2022-08-01-medication_resolver_pipeline_en_3_0.md
docs/_posts/gpirge/2022-08-08-bert_sequence_classifier_health_mandates_premise_tweet_en_3_0.md
docs/_posts/gpirge/2022-08-08-bert_sequence_classifier_health_mandates_stance_tweet_en_3_0.md
docs/_posts/gpirge/2022-08-11-bert_token_classifier_negation_uncertainty_es_3_0.md
docs/_posts/gpirge/2022-08-11-bert_token_classifier_ner_clinical_trials_abstracts_es_3_0.md
docs/_posts/gpirge/2022-08-11-bert_token_classifier_pharmacology_es_3_0.md
docs/_posts/gpirge/2022-08-12-ner_clinical_trials_abstracts_es_3_0.md
docs/_posts/gpirge/2022-08-13-ner_negation_uncertainty_es_3_0.md
docs/_posts/gpirge/2022-08-13-ner_pharmacology_es_3_0.md
docs/_posts/gpirge/2022-08-14-disease_mentions_tweet_es_3_0.md
docs/_posts/muhammetsnts/2022-08-28-ner_profiling_biobert_en.md
docs/_posts/muhammetsnts/2022-08-29-zero_shot_ner_roberta_en.md
docs/_posts/muhammetsnts/2022-08-30-ner_profiling_clinical_en.md
